Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Hepatosplenic schistosomiasis is a complex clinical condition caused by the complications of chronic infection with Schistosoma species that cause intestinal schistosomiasis. Hepatosplenic schistosomiasis derives from the fibrotic reaction stimulated around parasite eggs that are transported by the mesenteric circulation to the liver, causing periportal fibrosis. Portal hypertension and variceal gastrointestinal bleeding are major complications of hepatosplenic schistosomiasis. The clinical management of hepatosplenic schistosomiasis is not standardised and a parameter that could guide clinical decision making has not yet been identified. Transjugular intrahepatic portosystemic shunt (TIPS) appears promising for use in hepatosplenic schistosomiasis but is still reported in very few patients. In this Grand Round, we report one patient with hepatosplenic schistosomiasis treated with TIPS, which resulted in regression of oesophageal varices but had to be followed by splenectomy due to persisting severe splenomegaly and thrombocytopenia. We summarise the main challenges in the clinical management of this patient with hepatosplenic schistosomiasis, highlight results of a scoping review of the literature, and evaluate the use of of TIPS in patients with early hepatosplenic schistosomiasis, to improve the prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(23)00689-8DOI Listing

Publication Analysis

Top Keywords

hepatosplenic schistosomiasis
36
schistosomiasis
10
hepatosplenic
9
transjugular intrahepatic
8
intrahepatic portosystemic
8
portosystemic shunt
8
review literature
8
clinical management
8
patient hepatosplenic
8
shunt splenectomy
4

Similar Publications

The global burden of multimorbidity is increasing yet poorly understood, owing to insufficient methods for modelling complex systems of conditions. In particular, hepatosplenic multimorbidity has been inadequately investigated. From 17 January to 16 February 2023, we examined 3186 individuals aged 5-92 years from 52 villages across Uganda within the SchistoTrack Cohort.

View Article and Find Full Text PDF

Asian hepatointestinal schistosomiasis due to Schistosoma japonicum is prevalent in the Philippines and in Indonesia, while it is close to elimination in China. The second Asian schistosome, S. mekongi, is found in Cambodia and Laos.

View Article and Find Full Text PDF

Schistosoma (S.) mekongi is causing intestinal and hepatosplenic schistosomiasis in some South East Asian countries located along the Mekong river. Ultrasonography is the point of care method of choice for detecting and staging hepatosplenic morbidity due to schistosomiasis.

View Article and Find Full Text PDF

Hepatosplenic Schistosomiasis Presenting as Melena in an Adolescent Filipino Male: A Case Report and Literature Review.

Acta Med Philipp

April 2025

Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila.

Schistosomiasis, a snail-borne disease caused by infection with a trematode parasite of the genus Schistosoma, is one of the most neglected tropical diseases in the world. One of its rare complications is hepatosplenic schistosomiasis which ultimately leads to fibrosis and presinusoidal portal hypertension. We report a case of a 13-year-old Filipino male from Quezon City with previous one year residence in the endemic island of Leyte, presenting with melena.

View Article and Find Full Text PDF

Angiopoietins as biomarkers of schistosomiasis severity: a cross-sectional study.

Parasitology

March 2025

Faculdade de Medicina, Programa de Pós-Graduação em Ciências Médicas, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

Schistosomiasis, a parasitic disease caused by species, remains highly prevalent in tropical regions, where it contributes significantly to hepatic and vascular complications. Despite the well-established role of parasitic eggs in driving inflammation and organ damage, the specific vascular mechanisms remain poorly understood. Given the role of angiogenesis and vascular remodelling in tissue repair, the angiopoietins (ANGs) could be promising biomarkers to evaluate disease progression.

View Article and Find Full Text PDF